Thalidomide Apology 50 Years Later

Featured ArticleMain Category: Litigation / Medical MalpracticeAlso Included In: Pharma Industry / Biotech IndustryArticle Date: 01 Sep 2012 – 1:00 PDT

Current ratings for:Thalidomide Apology 50 Years Later

Gruenenthal Group’s CRO has apologized to moms who took Thalidomide in the 1950s and 1960s and gave birth to kids with congenital birth defects. Exactly 50 years ago today, Thalidomide was pulled off the market.

In the 1950s and 1960s, Thalidomide was approved in 46 countries for the treatment of morning sickness during pregnancy, as well as aiding sleep. It was not sold in the USA. Thalidomide became extremely popular in Australia, West-Germany, and the United Kingdom. It was taken off the market in 1961 after it was found to be closely linked to birth defects.

Unfortunately, by the time it had been pulled of the shelves, thousands of kids had been born with deformities. Worldwide, nobody knows exactly how many victims of the drug there were – estimates range from 10,000 up to 20,000.

There was a long trial in Germany. Gruenenthal set up a foundation to compensate those and their families who were affected by the drug. For the last 50 years many victims have stated that not enough was done, and that the company should apologize.

In 1972, eleven years after Thalidomide was withdrawn, the company settled a lawsuit and expressed “regret” to the victims. However, “regret” is very different from a full apology; it does not admit liability. In 1972, Gruenenthal stated it had followed all protocols regarding clinical trials.

On Friday, 31st August, 2012, exactly 50 years after the drug was taken off the market, Harald F. Stock, PhD., Chief Executive Officer of the Grünenthal Group, said: (translated from German)

“On behalf of Gruenenthal with its shareholders and all employees, I would like to take the opportunity at this moment of remembrance this day to express our sincere regrets about the consequences of Thalidomide and our deep sympathy for all those affected, their moms and their families. We see both the physical hardship and the emotional stress that the affected, their families and particularly their mothers, had to suffer because of Thalidomide and still have to endure day by day.”

We also apologize for the fact that we have not found the way to you from person to person for nearly 50 years. Instead, we have been silent and we are very sorry for that.”

On the 31st August, 2012, a bronze statue of a child born without limbs because of thalidomide was unveiled in the city of Stolberg, Germany.

Mixed response from Thalidomide victims’ organizationsEDRIC (European Dysmelia Reference Information Centre), which runs the on-line DysNet Limb Difference Network, announced that a full apology must be accompanied by help for all the victims who have had to live with physical impairments caused by thalidomide for the past five decades.

Geoff Adams Spink, Chairman of EDRIC and a thalidomide survivor, said:

“Having tried to remind them of their criminal behavior across a negotiating table on several occasions, I did not think this company would ever make things right. This is important first step. The next is to compensate everyone damaged by their so-called ‘totally harmless’ drug.”

UK charity, The Thalidomide Trust, is still this day trying to seek a permanent financial settlement for all those victims who reside in the United Kingdom and are having to live with progressively worsening health problems caused by their disabilities as they get older.

The DysNet Limb Difference Network wrote that in Australia, Thalidomider Lynette Rowe managed to secure a multi-million dollar settlement from the company that distributed the medication, Diageo, in a class action suit.

The Association of Contergan Victims described today’s apology as “too little, too late”. Ilonka Stebritz, spokesperson for the association, said:

“The apology as such doesn’t help us deal with our each day life. What we need are other things.”

Thalidomide was sold under the brand name “Contergan” in Germany.

Thalidomide is currently being studied for the treatment of some cancers and autoimmune diseases. It is used, under strict control, for the treatment of leprosy and multiple myeloma.

Frances Oldham Kelsey M.D. resisted pressure to approve thalidomide in the USAFrances Oldham Kelsey M.D., an American pharmacologist, resisted pressure from Richardson-Merrell, a pharmaceutical company, and turned down a submission for approval on behalf of the FDA (Food and Drug Administration).

Kelsey stuck to her guns and insisted that further studies on the drug were required. However, even though thalidomide was never granted to be sold in American, millions of tablets had been given to physicians during a clinical testing program. Nobody really knows how many pregnant moms were given these tablets for the treatment of morning sickness or to aid sleep.

Kelsey received an award from President John F. Kennedy in 1962 for refusing to grant thalidomide to be sold in the United States.

Written by Christian NordvistCopyright: Medical News TodayNot to be reproduced without permission of Medical News Today

Visit our litigation / medical malpractice section for the latest news on this subject. Sources: The Grünenthal Group, FDA, Wikipedia, http://www.dysnet.org Please use one of the following formats to cite this article in your essay, paper or report:

Please note: If no author information is provided, the source is cited instead.

Add Your Opinion On This Article’Thalidomide Apology 50 Years Later’

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

For any corrections of factual information, or to contact the editors please use our feedback form.Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Related News:

• Peak risk about 16 years old for teens misusing prescription drugs
• Half of First Marriages Don’t Last 20 Years
• Early Birth Tied To Health Risks In Early Years
• Drowning Rates Drop by Nearly Half Over 16 Years
• Many NIH-funded clinical trials go unpublished over two years after completion, U.S. study shows
• More Reasons To Keep This New Year’s Weight Loss Resolution Uncovered By Ben-Gurion U Researchers
• Smokers May Get Strokes 10 Years Before Nonsmokers
• The Marshmallow Test – One Now Or Two Later?
• Childhood Sexual Abuse Linked To Later Heart Attacks In Men
• Exercising Daily Lowers Alzheimer’s Risk, Even If You Start Later In Life

Details :
Submited at Saturday, September 1st, 2012 at 4:15 pm on Uncategorized by hilman
Comment RSS 2.0 - leave a comment - trackback